drugset / Trial / NCT01636492
A Study of Bitopertin (RO4917838) in Healthy Male Volunteers
RandomizedParallel-groupDouble-blind
Summary
This randomized, double-blind, placebo-controlled, dose-escalating study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of bitopertin in healthy male volunteers. Subjects will be randomized in cohorts to receive single oral doses of either bitopertin or placebo.
Timeline
- Start
- 2005-11
- Primary completion
- 2006-08
- Completion
- 2006-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | bitopertin | Small molecule | — | Oral |
Indications
No indication recorded.